Posted in | News | Medical Robotics

Xenex Signs Contract Covering Germ-Zapping Robots with HealthTrust

Xenex Disinfection Services today announced it has signed a national contract with HealthTrust℠, a leading group purchasing and total cost management organization that serves 1,350 acute care facilities nationwide. The contract, which covers Xenex Germ-Zapping Robots™, became effective June 1, 2015.

Xenex’s pulsed xenon Full Spectrum™ ultraviolet (UV) room disinfection solution reduces the bacterial load in hospitals that is often associated with an increased risk for healthcare-associated infections (HAIs). The robot pulses intense UV light covering the entire UV spectrum, destroying viruses, bacteria and bacterial spores in a five-minute disinfection cycle. Without contact or chemicals, the robot eliminates harmful microorganisms safely and effectively. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in nearly 300 hospitals, healthcare facilities of the U.S. Department of Veterans Affairs and Department of Defense, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities in the U.S. and Europe.

“We’re able to help hospitals provide a safer environment by eliminating the dangerous superbugs that pose a threat to patients and hospital workers,” said Morris Miller, CEO of Xenex.

“Xenex is dedicated to environmental responsibility and the safety of hospital employees and patients,” said Dr. Mark Stibich, Xenex co-founder and chief scientific officer. “Xenex germ-zapping robots use full spectrum pulsed xenon flash lamps instead of mercury bulbs to create germicidal UV light. Using the robots, hospital environmental services staff are able to disinfect 30 to 60 rooms per day―including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas―without disrupting hospital operations.”


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type